Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Ajanta Pharma promoter sells ₹1,024 crore stake; mutual funds step in as buyers
A promoter entity of Ajanta Pharma has sold a 2.8% stake in the drugmaker for over ₹1,000 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya Birla Sun Life Mutual Fund emerging as the key buyers.
Promoter sells Rs 1,024 crore worth of Ajanta Pharma shares in block deal to Kotak MF and ABSL MF
A promoter entity of Ajanta Pharma sold shares worth over Rs 1,024 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya Birla Sun Life Mutual Fund acquiring the stake. The transaction comes amid strong earnings growth, healthy margins and sustained momentum in the company’s pharmaceutical business.
Dr. Agarwal's Shares May Rally 35% on Strong Surgical Growth, Says Motilal Oswal — Check Target Price
Motilal Oswal remains bullish on Dr. Agarwal's structural growth story, backed by its leadership in the eye-care segment and a rapidly scaling surgical franchise.
Shares to buy or sell: Chandan Taparia of Motilal Oswal recommends 3 stocks to buy today amid RBI policy - 5 June 2026
Shares to buy or sell: Chandan Taparia has recommended three stocks to buy today, 5 June 2026 - BSE, Laurus Labs and Exide Industries shares.
Buy or sell: Gift Nifty signals big gap-down start, Vaishali Parekh recommends three stocks to buy today — 4 June 2026
Buy or sell stocks, 4 June 2026: Vaishali Parekh recommends three stocks to buy today — PNB, Oswal Pumps, and JK Tyre
Shares to buy or sell: Chandan Taparia of Motilal Oswal recommends three stocks to buy today - 2 June 2026 - Mint
Shares to buy or sell: Chandan Taparia of Motilal Oswal recommends three stocks to buy today - 2 June 2026Mint
Sensex Today | Stock Market LIVE Updates: GIFY Nifty hints at gap-down; Ashok Leyland in focus
Sensex Today | Stock Market LIVE Updates: Brent continues to remain below $100 a barrel and the bulls would take that with both hands. For levels, 24,000 continues to act as a barrier for the index, while a close above 23,800 will be crucial to head into the new month on a positive note.
Mphasis to Glenmark - Jay Thakkar suggests 3 stocks to buy or sell for short-term in F&O segment
The Indian stock market is set to open lower, with the Gift Nifty at 23,882, down 97 points. Benchmark indices fell on profit-taking and rising crude oil prices, leading to cautious sentiment. Nifty 50 faces immediate hurdles at 24,100 and support at 23,800.
Blue Jet Healthcare gains 8% post Q4; analysts split on near-term prospects
Emkay Global has retained its 'Reduce' rating, while Motilal Oswal has maintained its 'Buy' stance, reflecting contrasting expectations on recovery in key business segments and the margin trajectory
Shares to buy or sell: Chandan Taparia of Motilal Oswal recommends three stocks to buy today - 26 May 2026 - Mint
Shares to buy or sell: Chandan Taparia of Motilal Oswal recommends three stocks to buy today - 26 May 2026Mint
Sun Pharma Shares In Focus As Motilal Oswal Retains Bullish Call After Q4 — Check Target Price, Upside
Sun Pharma delivered in-line revenue in Q4, whereas Ebitda/PAT came in lower than expected, dragged down by higher marketing spending and lower milestone income.
Shares to buy or sell: Chandan Taparia of Motilal Oswal recommends three stocks to buy today - 22 May 2026 - Mint
Shares to buy or sell: Chandan Taparia of Motilal Oswal recommends three stocks to buy today - 22 May 2026Mint